Objective Base on the same content and purpose， Lingguizhugan Decoction integrative treatment of congestive heart failure， randomized control trials data classification， which is divided into 3 groups. Finally， the use of Review Manager-based Meta-analysis to contrast the efficacy treatment for congestive heart failure. Methods Search of relevant documents is required and uses. From 1949—2013 three database CNKI， CBM， VIP. Comprehensive screening of randomized clinical trials and research literature on Lingguizhugan Decoction for treatment of congestive heart failure. Use of Meta-analysis， Comparison and studies on Lingguizhugan Decoction to treat Congestive Heart Failure including OR， RR， RD. Results A total of 36 randomized controlled clinical study of literature， on 733 cases of patients， after Meta-analysis showed a significant difference between the groups compared. Among them， （1） Lingguizhugan Decoction+Western triple therapy > Western triple therapy： OR=3.54， 95% CI=[1.92， 6.56]， Z=4.03， P<0.0001； RR=1.25， 95% CI=[1.12， 1.40]， Z=4.07， P<0.0001； RD=-0.18， 95% CI=[-0.26， -0.10]， Z=4.36， P<0.0001。（2） Lingguizhugan Decoction+Western quadruple therapy>Western quadruple therapy： OR=4.83， 95% CI=[1.51， 15.41]， Z=2.66， P=0.008； RR=1.16， 95% CI=[1.04， 1.30]， Z=2.67， P=0.008； RD=-0.13， 95% CI=[-0.23， -0.04]， Z=2.81， P=0.005。（3） Lingguizhugan Decoction+Western six combination therapy >Western six combination therapy： OR=2.54， 95% CI=[1.28， 5.05]， Z=2.67， P=0.007； RR=1.22， 95% CI=[1.04， 1.43]， Z=2.49， P=0.01； RD=-0.15， 95% CI=[-0.27， -0.004]， Z=2.66， P=0.008. Conclusion From the above 3 statistical research groups， the best treatment result was obtained from the integrative medicine than with treatment using Western medicine alone.